Clinical trial · Interventional
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice Through Effective Communication of Personalized Cancer Risk
NCT03775213CI-TRIAL-00063523completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ductal Carcinoma in Situ | Breast Ductal Carcinoma In Situ | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Decision Support Tool with Active Monitoring | Behavioral | — | UNRESOLVED |
| Decision Support Tool without Active Monitoring | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Standard Treatment Options + Active Monitoring
- description
- Participants explore decision support tool that includes current standard treatment options for DCIS, as well as active monitoring.
- interventionNames
- Behavioral: Decision Support Tool with Active Monitoring
- type
- ACTIVE_COMPARATOR
- label
- Standard Treatment Options
- description
- Participants explore decision support tool that includes current standard treatment options for DCIS.
- interventionNames
- Behavioral: Decision Support Tool without Active Monitoring
Primary outcomes (1)
- measure
- Number of Participants Who Chose Active Monitoring (AM).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 50 Years
- Maximum age
- 79 Years
Show eligibility criteria text
Inclusion Criteria: * Sex: Female * Age: 50-79 years * Has had a negative mammographic screen in the past 12 months Exclusion Criteria: * Personal history of breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.